Epigallocatechin‐3‐gallate in combination with corticosteroids mitigates heat stress‐induced acute kidney injury through modulating heat shock protein 70 and toll‐like receptor 4‐dependent pathways

Faten Shafeek,Dalia H. El‐Kashef,Nashwa Abu‐Elsaad,Tarek Ibrahim
DOI: https://doi.org/10.1002/ptr.7834
IF: 6.388
2023-04-26
Phytotherapy Research
Abstract:Recently, recurrent heat stress (HS) and dehydration have been exhibited to give rise to kidney disease epidemic in hot regions. The current study was carried out to estimate a possible renoprotective effect of dexamethasone (Dexa) and epigallocatechin‐3‐gallate (EGCG) as a heat shock protein (HSP)‐70 inhibitor on HS‐induced nephropathy. In total, five groups of rats were used: control group, HS group (exposed to heat for 40 min), Dexa+HS group (rats were injected with Dexa i.p.15 mg/kg/day for 3 days followed by HS), EGCG+HS group (rats received EGCG 100 mg/kg/day, orally, for 7 days followed by HS), and EGCG+ Dexa +HS group (rats received EGCG 100 mg/kg/day, orally, for 7 days and injected Dexa as described along the last 3 days followed by HS). Kidney sections were stained with H&E and scored for tubular injury. A marked increase in creatinine, urea, malondialdehyde (MDA), monocyte chemoattractant protein (MCP)‐1, HSP‐70, nuclear factor kappa B (NF‐κB), toll‐like receptor 4 (TLR‐4) and Caspase‐3 expression was observed after HS induction (p
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?